SITANOW-50
| Brand | SITANOW-50 |
|---|---|
| Composition | Sitagliptin 50mg |
| Packing | 10x10 |
| Pack Type | Tab |
For pharmaceutical trade buyers, not patient or consumer sales. This record reproduces company product information, not medical advice. Current product availability and terms are confirmed by Intra Life.
Enquire about SITANOW-50Indication
As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Mechanism of action
Sitagliptin inhibits the DPP-4 enzyme, which prolongs the activity of incretin hormones. This supports glucose-dependent insulin release and reduces glucagon secretion.
For pharmaceutical trade information. Refer to the current approved product insert and the prescribing clinician for patient-specific use.
SITANOW-50 for B2B enquiries
Distributors, stockists, medical stores, hospitals and PCD franchise buyers can share their city, quantity and product requirements. Ask the team for current supply, packing and trade terms.
Ask for trade details on WhatsAppKeep exploring
Browse related brand searches · All published products · Browse divisions
Explore products with a matching ingredient term
For catalogue browsing only, not substitutions. Formulations and strengths differ.
SUGAVIA-M 500
SUGAVIA-100
SITANOW-M 1000
DAPASUG-SM-500